United States: Join Us for the Final Installment of Our 21st Century Cures Act Webinar Series
Last Updated: February 10 2017

Join us next Wednesday, February 15 from 1pm – 2pm Eastern for the final installment of our three-part webinar series on the 21st Century Cures Act (the "Cures Act").  Part III of the series will focus on the Cures Act's impact on the FDA and will have some great takeaways for anyone who interacts with the FDA or has an interest in the Cures Act.

In this presentation, our colleagues Bethany Hills and Joanne Hawana will discuss the following FDA-related provisions of the Cures Act and take a deep dive into the practical implications and implementation processes for each of:

  • Regenerative Medicine
  • Medical software/digital health
  • FDA restructuring/structural improvements
  • Health care economic info and off-label communications
  • Data source changes – patient experience, RWE and summary data

Click HERE to register!

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Patricia Moran
By Peter Gelzinis
By Eli Greenspan, Katie Weider, Rodney Whitlock
By Natalie Young
By Joseph G. Blute, Yalonda T. Howze, Clancy Galgay
By Donald C. Davis
By Mark M. Higgins
By Michael Renaud, Adam Rizk, Jinnie L. Reed
By Mintz Levin Immigration Group
By Sahir Surmeli
Font Size: